Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial

BACKGROUND: Stereotactic body radiotherapy (SBRT) is becoming increasingly used in treating localized prostate cancer (PCa), with evidence showing similar toxicity and efficacy profiles when compared with longer courses of definitive radiation. Magnetic resonance imaging (MRI)-guided radiotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ting Martin, Lamb, James M., Casado, Maria, Wang, Xiaoyan, Basehart, T. Vincent, Yang, Yingli, Low, Daniel, Sheng, Ke, Agazaryan, Nzhde, Nickols, Nicholas G., Cao, Minsong, Steinberg, Michael L., Kishan, Amar U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114498/
https://www.ncbi.nlm.nih.gov/pubmed/33975579
http://dx.doi.org/10.1186/s12885-021-08281-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114498/
https://www.ncbi.nlm.nih.gov/pubmed/33975579
http://dx.doi.org/10.1186/s12885-021-08281-x

Ejemplares similares